Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Hakan TABAN"'
Autor:
Metin Demir, Denizcan Güven, Burak Yasin Aktaş, Gürkan Güner, Oktay Halit Aktepe, Hakan Taban, Yusuf Karakaş, Sadettin Kılıçkap, Ayşe Kars, Alev Türker, Ömer Dizdar
Publikováno v:
South Asian Journal of Cancer, Vol 11, Iss 04, Pp 287-292 (2022)
Objective Liposarcomas are relatively rare tumors. Prognostic and predictive factors and treatment options are limited. We herein presented our 10-year experience with liposarcomas. Materials and Methods Adult patients with liposarcoma treated betwee
Externí odkaz:
https://doaj.org/article/d48e7724c2054aaea29d505e552abdc2
Autor:
Hasan Çağrı YILDIRIM, Deniz Can GÜVEN, Elvin CHALABIYEV, Hakan TABAN, Feride YILMAZ, Serkan YAŞAR, Fatih KUŞ, Arif AKYILDIZ, Süleyman Çağın GÜRBÜZ, Hüseyin SAYIN, Gözde KAVGACI, Şuayib YALÇIN, Ömer DİZDAR
Publikováno v:
Journal of Oncological Sciences. 8:143-147
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9050e71245d8c1d1cb07bf54d3e1f4be
https://doi.org/10.37047/jos.2022-92230
https://doi.org/10.37047/jos.2022-92230
Autor:
Gurkan Guner, Omer Dizdar, Melek Seren Aksun, Suayib Yalcin, Hasan Cagri Yildirim, Taha Koray Sahin, Saadettin Kilickap, Mustafa Erman, Sercan Aksoy, Burak Yasin Aktas, Hakan Taban, Deniz Can Guven, Oktay Halit Aktepe
Publikováno v:
Biomarkers in Medicine. 15:1123-1130
Aim: Blood-based biomarkers like prognostic nutritional index (PNI) are readily available biomarkers for immunotherapy efficacy, although the data are limited. So, we aimed to evaluate the association between PNI and overall survival (OS) in immunoth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b67dce517d19d462d1370a7e37d7e6f7
https://doi.org/10.2217/bmm-2020-0674
https://doi.org/10.2217/bmm-2020-0674
Autor:
Hasan Cagri Yildirim, Deniz Can Guven, Oktay Halit Aktepe, Hakan Taban, Feride Yilmaz, Serkan Yasar, Sercan Aksoy, Mustafa Erman, Saadettin Kilickap, Suayib Yalcin
Publikováno v:
Journal of Clinical Medicine; Volume 11; Issue 17; Pages: 5171
Purpose: With the widespread use of immunotherapy agents, we encounter treatment responses such as hyperprogression disease (HPD) that we have not seen with previous standard chemotherapy and targeted therapies. It is known that survival in patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::076a3a65b07806af6a5f84edd161da81
Autor:
Deniz Yuce, Oktay Halit Aktepe, Deniz Can Guven, Fadime Sinem Ardıç, Mustafa Erman, Haci Hasan Yeter, Taha Koray Sahin, Gurkan Guner, Hakan Taban, Hasan Cagri Yildirim
Publikováno v:
Turk J Urol
OBJECTIVE: The albumin to globulin ratio (AGR) has been demonstrated to be associated with survival outcomes in various tumor types. However, the prognostic value of AGR in patients with metastatic renal carcinoma (mRCC) remains unclear. Therefore, t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d3fc605cb8583be551228190af5edb1
https://doi.org/10.5152/tud.2021.20377
https://doi.org/10.5152/tud.2021.20377
Autor:
Omer Diker, Recep Ak, Berna Oksuzoglu, Deniz Can Guven, Neyran Kertmen, Polat Olgun, Hakan Taban, Onur Bas, Bahadir Koylu, Burak Yasin Aktas, Sercan Aksoy
Publikováno v:
Cancer Research. 81:PS10-52
BackgroundInvasive breast cancers are characterized by overexpression or amplification of the human epidermal growth factor receptor 2 (HER2) approximately 15 to 25%. Survival outcomes was improved after introduction of Trastuzumab treatment. Trastuz
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f5d173d14311af24f7926ba278f2ed84
https://doi.org/10.1158/1538-7445.sabcs20-ps10-52
https://doi.org/10.1158/1538-7445.sabcs20-ps10-52
Autor:
Kadriye Bir Yucel, Umut Demirci, Hatime Arzu Yasar, Yuksel Urun, Burak Bilgin, Mehmet An Şendur, Hakan Taban, Bulent Yalcin, Nuri Karadurmus, Cagatay Arslan, Gokhan Ucar, Serdar Karakaya, Nuriye Yildirim, Ismail Erturk, Irfan Cicin, Ahmet Kucukarda, Saadettin Kilickap, Mutlu Hizal
Publikováno v:
Journal of Oncology Pharmacy Practice. 26:1583-1589
Background To describe the prognostic value of neutrophil–lymphocyte ratio and its effect on survival in in patients with advanced renal cell carcinoma. Methods We retrospectively analyzed 331 patients. The cut-off value of neutrophil–lymphocyte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cedf56b5fd9cd8a480ef474f54f9acd4
https://doi.org/10.1177/1078155219900908
https://doi.org/10.1177/1078155219900908
Crizotinib and entrectinib are approved tyrosine kinase inhibitors by the FDA to treat advanced-stage ROS1-positive non-small cell lung cancer (NSCLC). Although, entrectinib could be used after crizotinib, it is unknown whether crizotinib is effectiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ecedd81cb2692dfe18ad9321a375ddbf
https://hdl.handle.net/20.500.12713/3321
https://hdl.handle.net/20.500.12713/3321
Autor:
Furkan Ceylan, Deniz Can Guven, Hakan Taban, Oktay Aktepe, Taha Koray Sahin, Sadettin Kilickap, Alev Turker, Erhan Hamaloglu, Derya Karakoc, Aynur Isik, Aytekin Akyol, Suayib Yalcin, Omer Dizdar
Publikováno v:
Clinics and Research in Hepatology and Gastroenterology. 47:102091
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e37150f11205c2769b62ceae69d64902
https://doi.org/10.1016/j.clinre.2023.102091
https://doi.org/10.1016/j.clinre.2023.102091
Autor:
Hasan Çağrı Yıldırım, Deniz Can Guven, Oktay Halit Aktepe, Hakan Taban, Feride Yilmaz, Serkan Yasar, Burak Yasin Aktaş, Gürkan Güner, Ömer Dizdar, Sercan Aksoy, Mustafa Erman, Suayib Yalcin, Saadettin Kilickap
Background Although the immune checkpoint inhibitors (ICIs) became a vital part of cancer care, many patients do not respond to treatment. Some of the patients in this group, which is considered to have hyperprogressive disease (HPD), have a shorter
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d2dee46c5714fde7e79896e59f2cdcb0
https://doi.org/10.21203/rs.3.rs-1184111/v1
https://doi.org/10.21203/rs.3.rs-1184111/v1